2023 Regular Session ENROLLED
SENATE BILL NO. 14
BY SENATOR BERNARD
Prefiled pursuant to Article III, Section 2(A)(4)(b)(i) of the Constitution of Louisiana.
1 AN ACT
2 To amend and reenact R.S. 40:964(Schedule I)(E)(1)(i) and (iii) and (8) and (F)(1) through
3 (8), (12), (17) through (22), and (24) through (29) and (Schedule V)(D)(6), to enact
4 R.S. 40:964(Schedule I)(A)(100) and (E)(14) through (16), (Schedule IV)(B)(58),
5 and (Schedule V)(D)(7) and 989.1(C)(2)(nn), and to repeal R.S. 40:964(Schedule
6 IV)(C), relative to the Uniform Controlled Dangerous Substances Law; to add certain
7 substances to Schedules I, IV, and V; to remove substances from Schedule IV; to
8 provide for updated structural language; to provide for unlawful hallucinogenic
9 plants; and to provide for related matters.
10 Be it enacted by the Legislature of Louisiana:
11 Section 1. R.S. 40:964(Schedule I)(E)(1)(i) and (iii) and (8) and (F)(1) through (8),
12 (12), (17) through (22), and (24) through (29) and (Schedule V)(D)(6) are hereby amended
13 and reenacted and R.S. 40:964(Schedule I)(A)(100) and (E)(14) through (16), (Schedule
14 IV)(B)(58), and (Schedule V)(D)(7) and 989.1(C)(2)(nn) are hereby enacted to read as
15 follows:
16 §964. Composition of schedules
17 Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S.
18 40:962, consist of the following drugs or other substances, by whatever official
19 name, common or usual name, chemical name, or brand name designated:
20 SCHEDULE I
21 A. Opiates. Unless specifically excepted or unless listed in another schedule,
22 any of the following opiates, including their isomers, esters, ethers, salts, or salts of
23 isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers,
24 or salts is possible within the specific chemical designation:
25 * * *
ACT No. 201
Page 1 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 14 ENROLLED
1 (100) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)
2 piperazin-1-yl]-1-phenylpropan-2-ol)
3 * * *
4 E. Stimulants. Unless specifically excepted, or contained within a
5 pharmaceutical product approved by the United States Food and Drug
6 Administration, or unless listed in another schedule, any material, compound,
7 mixture, or preparation which contains any quantity of the following substances
8 having a stimulant effect on the central nervous system including its salts, isomers,
9 esters, or ethers and salts of isomers, esters, or ethers whenever the existence of such
10 salts, isomers, esters, or ethers and salts of isomers, esters, or ethers is possible
11 within the specific chemical designation:
12 (1) 2-amino-1-phenyl-1-propanone (cathinone) or variation in any of the
13 following ways:
14 (i) By substitution in on the phenyl ring to any extent with an alkyl, hydroxyl
15 alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further
16 substituted in on the phenyl ring by one or more other univalent substituents.
17 * * *
18 (iii) By substitution at the 2-amino nitrogen atom with alkyl, cycloalkyl,
19 dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen
20 atom in a cyclic structure.
21 * * *
22 (8) Naphthylpyrovalerone whether or not further substituted in on the
23 naphthyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide
24 substituents, whether or not further substituted in on the naphthyl ring by one or
25 more other univalent substituents or whether or not further substituted in on the
26 carbon chain at the 3, 4, or 5 position with an alkyl substituent.
27 * * *
28 (14) Amineptine (7-[(10,11-dihydro-5H-dibenzo
29 [a,d]cyclohepten-5-yl)amino]heptanoic acid)
30 (15) Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-
Page 2 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 14 ENROLLED
1 1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)
2 (16) Methiopropamine (N-methyl-1-(thiophen-2-yl)propane-2-amine)
3 F. Synthetic cannabinoids. Unless specifically excepted, or contained within
4 a pharmaceutical product approved by the United States Food and Drug
5 Administration, or unless listed in another schedule, any material, compound,
6 mixture, or preparation which contains any quantity of a synthetic cannabinoid found
7 to be in any of the following individual compounds or chemical groups, or any of
8 those individual compounds or groups which contain any synthetic cannabinoid salts,
9 isomers, salts of isomers, or nitrogen-heterocyclic analogs, whenever the existence
10 of such salts, isomers, salts of isomers, or nitrogen-heterocyclic analogs is possible
11 within the specific compounds or chemical groups:
12 (1) Adamantoylindoles: any compound containing a 3-(1-adamantoyl)indole
13 structure, whether or not further substituted in on the indole ring to any extent or
14 whether or not substituted in on the adamantyl ring to any extent.
15 (2) Adamantylamidoindoles: Any compound containing a N-(adamantyl)-1H-
16 indole-3-carboxamide structure, whether or not further substituted in on the indole
17 ring to any extent or whether or not substituted in on the adamantyl ring to any
18 extent.
19 (3) Benzoylindoles: any compound containing a 3-(benzoyl)indole structure,
20 whether or not substituted in on the indole ring to any extent or whether or not
21 substituted on the phenyl ring to any extent.
22 (4) Benzylindolecarboxamides: Any compound containing a
23 N-benzyl-1H-indole-3-carboxamide structure, whether or not further substituted in
24 on the indole ring or whether not substituted on the phenyl ring to any extent.
25 (5) Butaldehydeamidoindoles: Any compound containing a
26 N-(1-oxobutan-2yl)-1H-indole-3-carboxamide structure, with or without substitution
27 in on the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkoxy, aryl, aryl halide,
28 alkylarylhalide, cycloalkymethyl, arylalkylhalide, cycloalkylmethyl,
29 cycloalkylethyl, alkenyl, haloalkenyl, aliphatic alcohol, hydroxyl, halide,
30 morpholinoethyl, alkylmorpholinomethyl, alkylpiperidinylmethyl or a
Page 3 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 14 ENROLLED
1 tetrahydropyranylmethyl group, whether or not further substituted on the
2 butaldehyde group to any extent.
3 (6) Cumylindolecarboxamides: Any compound containing a
4 N-(2-phenylpropane-2-yl)-1H-indole-3-carboxamide structure, with or without
5 substitution in on the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkoxy, aryl, aryl
6 halide, alkylarylhalide, cycloalkymethyl, arylalkylhalide, cycloalkylmethyl,
7 cycloalkylethyl, alkenyl, haloalkenyl, aliphatic alcohol, hydroxyl, halide,
8 morpholinoethyl, alkylmorpholinomethyl, alkylpiperidinylmethyl or a
9 tetrahydropyranylmethyl group, whether or not further substituted on the phenyl
10 group to any extent.
11 (7) Cyclohexylphenols: any compound containing a 2-(3-
12 hydroxycyclohexyl)phenol structure, whether or not substituted in on the cyclohexyl
13 ring to any extent or whether or not substituted on the phenyl ring to any extent.
14 (8) Cyclopropanoylindoles: any compound containing a 3-
15 (cyclopropanoyl)indole structure, whether or not substituted in on the indole ring to
16 any extent or whether or not substituted on the cyclopropyl ring to any extent.
17 * * *
18 (12) Hexahydrodibenzopyrans whether or not substituted in on the tricyclic
19 ring system to any extent except where contained in cannabis or cannabis resin.
20 * * *
21 (17) Naphthoylindoles: any compound containing a 3-(1-naphthoyl)indole
22 structure, whether or not substituted in on the indole ring to any extent or whether
23 or not substituted on the naphthyl ring to any extent.
24 (18) Naphthoylpyrroles: any compound containing a 3-(1-naphthoyl)pyrrole
25 structure, whether or not substituted in on the pyrrole ring to any extent or whether
26 or not substituted on the naphthyl ring to any extent.
27 (19) Naphthylamidoindoles: any compound containing a N-(naphthyl)-1H-
28 indole-3-carboxamide structure, whether or not further substituted in on the indole
29 ring to any extent or whether or not substituted in on the naphthyl ring to any extent.
30 (20) Naphthylindolecarboxylates: Any compound containing a
Page 4 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 14 ENROLLED
1 naphthyl-1H-indole-3-carboxylate structure, whether or not further substituted in on
2 the indole ring or whether or not substituted on the naphthyl ring to any extent.
3 (21) Naphthylmethylindenes: any compound containing a 1-(1-
4 naphthylmethyl)indene structure, whether or not substituted in on the indene ring to
5 any extent or whether or not substituted on the naphthyl ring to any extent.
6 (22) Naphthylmethylindoles: any compound containing a 1-H-indol-3-yl-(1-
7 naphthyl)methane structure, whether or not substituted in on the indole ring to any
8 extent or whether or not substituted on the naphthyl ring to any extent.
9 * * *
10 (24) Phenylacetylindoles: any compound containing a 3-phenylacetylindole
11 structure, whether or not substituted in on the indole ring to any extent or whether
12 or not substituted on the phenyl ring to any extent.
13 (25) Phenylindolecarboxamides: Any compound containing a
14 N-phenyl-1H-indole-3-carboxamide structure, whether or not further substituted in
15 on the indole ring or whether or not substituted on the phenyl ring to any extent.
16 (26) Phenylpropionaldehydeamidoindoles: Any compound containing a
17 N-(1-oxo-3-phenylpropan-2yl)-1H-indole-3-carboxamide structure, with or without
18 substitution in on the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkoxy, aryl, aryl
19 halide, alkylarylhalide, cycloalkymethyl, arylalkylhalide, cycloalkylmethyl,
20 cycloalkylethyl, alkenyl, haloalkenyl, aliphatic alcohol, hydroxyl, halide,
21 morpholinoethyl, alkylmorpholinomethyl, alkylpiperidinylmethyl or a
22 tetrahydropyranylmethyl group, whether or not further substituted on the
23 phenylpropionaldehyde group to any extent.
24 (27) Quinolinylindolecarboxamides: Any compound containing a N-
25 quinolinyl-1H-indole-3-carboxamide or N-isoquinolinyl-1H-indole-3-carboxamide
26 structure, whether or not further substituted in on the indole, quinoline or the
27 isoquinoline ring to any extent.
28 (28) Quinolinylindolecarboxylates: any compound containing a
29 quinolin-8-yl-1H-indole-3-carboxylate or isoquinolin-8-yl-1H-indole-3-carboxylate
30 structure, whether or not further substituted in on the indole, quinloline, or
Page 5 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 14 ENROLLED
1 isoquinoline ring to any extent.
2 (29) Tetrahydrodibenzopyrans whether or not substituted in on the tricyclic
3 ring system to any extent except where contained in cannabis or cannabis resin.
4 * * *
5 SCHEDULE IV
6 * * *
7 B. Depressants.
8 Unless specifically excepted or unless listed in another schedule, any
9 material, compound, mixture, or preparation containing any quantity of the following
10 substances, including its salts, isomers, and salts of isomers, whenever the existence
11 of such salts, isomers, and salts of isomers is possible within the specific chemical
12 designation:
13 * * *
14 (58) Daridorexant
15 * * *
16 SCHEDULE V
17 * * *
18 D. Depressants. Unless specifically exempted or excluded or unless listed in
19 another schedule, any material, compound, mixture, or preparation which contains
20 any quantity of the following substances having a depressant effect on the central
21 nervous system, including its salts:
22 * * *
23 (6) Pregbalin Pregabalin
24 (7) Ganaxolone (3-á-hydroxy-3-â-methyl-5-á-pregnan-20-one)
25 * * *
26 §989.1. Unlawful production, manufacture, distribution, or possession of
27 hallucinogenic plants; exceptions
28 * * *
29 C. For the purposes of this Section:
30 * * *
Page 6 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 14 ENROLLED
1 (2) "Hallucinogenic plant" means any part or portion of any of the
2 following:
3 * * *
4 (nn) Amanita pantherina.
5 * * *
6 Section 2. R.S. 40:964(Schedule IV)(C) is hereby repealed.
7 Section 3. The Louisiana State Law Institute is hereby authorized and directed to
8 renumber the substances in R.S. 40:964(Schedule I)(A), (C), and (E), (Schedule IV)(B), and
9 (Schedule V)(D) to ensure that the substances are in alphabetical order.
PRESIDENT OF THE SENATE
SPEAKER OF THE HOUSE OF REPRESENTATIVES
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 7 of 7
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.